Factor V Leiden Mutation and Implantation Failure
Completed
Conditions studied: Infertility
In brief
The purpose of this study is to determine whether inherited thrombophilias (tendency toward blood clotting) increase the risk of failure of the embryo to implant in IVF. The specific condition to be studied is the presence or absence of the Leiden mutation of the Factor V gene.
Key facts
- Study ID
- NCT00194350
- Run by
- University of Pennsylvania
- People needed
- 399
- Starts
- 2001-09-01
- Expected to finish
- 2005-08-01
- Last updated by the study team
- 2011-08-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women undergoing in-vitro fertilization with successful ovarian hyperstimulation, oocyte retrieval, and fertilization
- Transfer of at least 2 fresh embryos of Grade 2 (preembryo with blastomeres of equal size and <=10% cytoplasmic fragmentation) or better
You may not qualify if…
- Infertility due to uterine anatomic defect
- Current use of anticoagulant medication, such as heparin or aspirin
- Known presence of any other condition associated with increased risk of thrombosis
Where it is running
- University of Pennsylvania Reproductive Research Unit — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.